| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |